Your Health, We Care
Release date: 2024-07-10 14:43:32 Recommended: 156
Finerenone is a non steroidal selective mineralocorticoid receptor antagonist that has been shown in preclinical studies to block harmful effects caused by excessive activation of mineralocorticoid receptors. In patients with diabetes, over activation of the mineralocorticoid receptor is believed to lead to the progression of chronic kidney disease and cardiovascular damage, which may be driven by factors such as metabolism, hemodynamics or inflammation and fibrosis.
At a grand pharmaceutical exhibition held recently in Dubai, Lucius Company of L···【more】
Recommended：353Release date: 2024-07-09
On October 18-19, 2023, Dr. Luís Meirinhos Soares, a microbiology expert appoint···【more】
Recommended：362Release date: 2024-07-09
On October 19, 2023, the World Health Organization (WHO) conducted a comprehensi···【more】
Recommended：422Release date: 2024-07-09
At present, the competition in all walks of life is very fierce, especially in t···【more】
Recommended：283Release date: 2024-07-09
Here are some key points about Lucius Pharmaceutical:Lucius Pharmaceuticals has ···【more】
Recommended：476Release date: 2024-07-09
From the Black Sea, the most terrifying ocean on earth, to the Mediterranean Sea···【more】
Recommended：294Release date: 2024-07-09
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently mad···【more】
Recommended：461Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest incr···【more】
Recommended：365Release date: 2024-07-09
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the r···【more】
Recommended：67Release date: 2025-12-17
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved nirap···【more】
Recommended：60Release date: 2025-12-15
The U.S. Food and Drug Administration (FDA) announced today that it has approved···【more】
Recommended：79Release date: 2025-12-10
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisoca···【more】
Recommended：74Release date: 2025-12-08
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full ap···【more】
Recommended：94Release date: 2025-12-04
Primary analysis data from the randomized, double-blind, placebo-controlled phas···【more】
Recommended：89Release date: 2025-12-01
